SCHEMBL1379286

SCHEMBL1379286

COc1ccc(S(=O)(=O)n2cc(-c3ccc(N)nc3)cc2-c2cc(OC)ccc2OC)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
ALPL P05186 1/20 0.43
HTR6 P50406 4/20 0.39
DRD2 P14416 2/20 0.39
HTR2A P28223 1/20 0.39
HTR7 P34969 1/20 0.39
BRD4 O60885 1/20 0.39
MAPT P10636 3/20 0.39
NR1I2 O75469 2/20 0.39
KDM4E B2RXH2 2/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CA13 Q8N1Q1 1/20 0.38
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1375792 0.86 FYN (0.46) MEN1KMT2AALPLBRD4MAPT
SCHEMBL1375760 0.69 CYP11B2 (0.48) ALDH1A1KMT2AALPLKDM4EHPGD
SCHEMBL4500005 0.68 LTA4H (0.61) KMT2AMAPTFYN
SCHEMBL1378956 0.65 CYP11B1 (0.47) ALDH1A1ALPLMAPTLMNAFYN
SCHEMBL5550517 0.62 ALOX5AP (0.53) ALDH1A1MEN1KMT2AALPLMAPT
SCHEMBL12486978 0.62 MAP4K4 (0.62) FYN
SCHEMBL6163752 0.62 KDM4E (0.60) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL3371555 0.62 CA12 (0.43) ALDH1A1MEN1KMT2AHTR6MAPT
SCHEMBL333949 0.62
SCHEMBL29715865 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4716996-B2 2011-07-06 JP claimed
EP-1628957-B1 SULFOPYRROLES TAKEDA PHARMACEUTICAL (JP) 2010-09-29 EP claimed
US-20070060570-A1 Sulfopyrroles TALEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-15 US claimed
EP-1628957-A1 SULFOPYRROLES Takeda Pharmaceutical Company Limited (JP) 2006-03-01 EP claimed
WO-2004103968-A1 SULFOPYRROLES APONETICS AG (CH) 2004-12-02 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060570-A1 Sulfopyrroles TYK2, ARSA, SULT2A1 ALDH1A1 1078/4885MEN1 739/4885KMT2A 2214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.